Personal information

No personal information available

Activities

Works (50 of 56)

Items per page:
Page 1 of 2

ASCEND-Eye: effects of aspirin on diabetic retinopathy

Ophthalmology
2024 | Journal article
Contributors: Sammons, E; Buck, G; Bowman, L; Stevens, W; Hammami, I; Parish, S; Armitage, J
Source: Self-asserted source
William Stevens

Clinical trial results in context: comparison of baseline characteristics and outcomes of 38,510 RECOVERY trial participants versus a reference population of 346,271 people hospitalised with COVID-19 in England

Trials
2024 | Journal article
Contributors: Pessoa-Amorim, Guilherme; Goldacre, Raphael; Crichton, Charles; Stevens, Will; Nunn, Michelle; King, Andy; Murray, Dave; Welsh, Richard; Pinches, Heather; Rees, Andrew et al.
Source: Self-asserted source
William Stevens

Design, recruitment, and baseline characteristics of the LENS trial

Diabetic Medicine
2024 | Journal article
Contributors: Preiss, D; Logue, J; Sammons, E; Zayed, M; Emberson, J; Wade, R; Wallendszus, K; Stevens, W; Armitage, J
Source: Self-asserted source
William Stevens

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Nature Communications
2024 | Journal article
Contributors: Sandercock, Peter; Darbyshire, Janet; DeMets, David; Fowler, Robert; Lalloo, David; Munavvar, Mohammed; Warris, Adilia; Wittes, Janet; Cradduck-Bamford, A; Barton, J et al.
Source: Self-asserted source
William Stevens

Effect of Fenofibrate on Progression of Diabetic Retinopathy

NEJM Evidence
2024 | Journal article
Contributors: Preiss, David; Logue, Jennifer; Sammons, Emily; Zayed, Mohammed; Emberson, Jonathan; Wade, Rachel; Wallendszus, Karl; Stevens, Will; Cretney, Rosanna; Harding, Simon et al.
Source: Self-asserted source
William Stevens

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

The Lancet Diabetes & Endocrinology
2024 | Journal article
Contributors: Judge, PK; Staplin, N; Mayne, KJ; Wanner, C; Green, JB; Hauske, SJ; Emberson, JR; Preiss, D; Ng, SYA; Roddick, AJ et al.
Source: Self-asserted source
William Stevens

ASCEND-Eye: Effects of Omega-3 Fatty Acids on Diabetic Retinopathy

Ophthalmology
2023 | Journal article
Contributors: Sammons, Emily L; Buck, Georgina; Bowman, Louise J; Stevens, William M; Hammami, Imen; Parish, Sarah; Armitage, Jane; ASCEND Study Collaborative Group; others
Source: Self-asserted source
William Stevens

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the EMPA-KIDNEY trial

The Lancet Diabetes & Endocrinology
2023 | Journal article
Contributors: Staplin, N; Haynes, R; Judge, PK; Wanner, C; Green, JB; Emberson, J; Preiss, D; Mayne, KJ; Ng, SYA; Sammons, E et al.
Source: Self-asserted source
William Stevens

Empagliflozin in patients with chronic kidney disease

New England Journal of Medicine
2023 | Journal article
Contributors: EMPA-Kidney Collaborative Group
Source: Self-asserted source
William Stevens

Reliability of major bleeding events in UK routine data versus clinical trial adjudicated follow-up data

Heart
2023 | Journal article
Contributors: Harper, Charlie; Mafham, Marion; Herrington, William; Staplin, Natalie; Stevens, William; Wallendszus, Karl; Haynes, Richard; Landray, Martin J; Parish, Sarah; Bowman, Louise et al.
Source: Self-asserted source
William Stevens

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Lancet (London, England)
2022 | Journal article
Contributors: RECOVERY Collaborative Group; others
Source: Self-asserted source
William Stevens

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Lancet (London, England)
2022 | Journal article
Contributors: RECOVERY Collaborative Group; others
Source: Self-asserted source
William Stevens

Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial

Nephrology Dialysis Transplantation
2022 | Journal article
Source: Self-asserted source
William Stevens

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial

European Heart Journal
2022 | Journal article
Contributors: Parish, Sarah; Mafham, Marion; Offer, Alison; Barton, Jill; Wallendszus, Karl; Stevens, William; Buck, Georgina; Haynes, Richard; Collins, Rory; Bowman, Louise et al.
Source: Self-asserted source
William Stevens

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial

European Heart Journal
2022-06-01 | Journal article
Contributors: Sarah Parish; Marion Mafham; Alison Offer; Jill Barton; Karl Wallendszus; William Stevens; Georgina Buck; Richard Haynes; Rory Collins; Louise Bowman et al.
Source: check_circle
Crossref

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Lancet (London, England)
2021 | Journal article
Contributors: RECOVERY Collaborative Group; others
Source: Self-asserted source
William Stevens

Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet Respiratory Medicine
2021 | Journal article
Contributors: RECOVERY Collaborative Group; others
Source: Self-asserted source
William Stevens

Comparison of routinely collected data with clinical trial adjudicated direct follow-up: post-hoc analyses of serious cardiovascular events from the United Kingdom-based ASCEND randomized trial

JAMA Network Open
2021 | Journal article
Contributors: Harper, C; Mafham, M; Herrington, W; Staplin, N; Stevens, W; Wallendszus, K; Haynes, R; Landray, M; Parish, S; Bowman, L et al.
Source: Self-asserted source
William Stevens

Comparison of the Accuracy and Completeness of Records of Serious Vascular Events in Routinely Collected Data vs Clinical Trial--Adjudicated Direct Follow-up Data in the UK: Secondary Analysis of the ASCEND Randomized Clinical Trial

JAMA Network Open
2021 | Journal article
Contributors: Harper, Charlie; Mafham, Marion; Herrington, William; Staplin, Natalie; Stevens, William; Wallendszus, Karl; Haynes, Richard; Landray, Martin J; Parish, Sarah; Bowman, Louise et al.
Source: Self-asserted source
William Stevens

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Lancet (London, England)
2021 | Journal article
Contributors: RECOVERY Collaborative Group; others
Source: Self-asserted source
William Stevens

Dexamethasone in hospitalized patients with Covid-19

New England Journal of Medicine
2021 | Journal article
Contributors: RECOVERY Collaborative Group
Source: Self-asserted source
William Stevens

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease

European heart journal
2021 | Journal article
Contributors: Sammons, E; Hopewell, JC; Chen, F; Stevens, W; Wallendszus, K; Valdes-Marquez, E; Dayanandan, R; Knott, C; Murphy, K; Wincott, E et al.
Source: Self-asserted source
William Stevens

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Lancet (London, England)
2021 | Journal article
Contributors: RECOVERY Collaborative Group; others
Source: Self-asserted source
William Stevens

Effect of hydroxychloroquine in hospitalized patients with Covid-19

New England Journal of Medicine
2020 | Journal article
Contributors: RECOVERY Collaborative Group
Source: Self-asserted source
William Stevens

The True Colours Remote Symptom Monitoring System: A Decade of Evolution

Journal of Medical Internet Research
2020 | Journal article
Contributors: Goodday, Sarah M; Atkinson, Lauren; Goodwin, Guy; Saunders, Kate; South, Matthew; Mackay, Clare; Denis, Mike; Hinds, Chris; Attenburrow, Mary-Jane; Davies, Jim et al.
Source: Self-asserted source
William Stevens

Effects of omega- 3 fatty acid supplements on arrhythmias

Circulation
2019 | Journal article
Contributors: Parish, S; Mafham, M; Offer, A; Barton, J; Wallendszus, K; Stevens, W; Buck, G; Haynes, R; Collins, R; Bowman, L et al.
Source: Self-asserted source
William Stevens

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus

New England Journal of Medicine
2018 | Journal article
Contributors: ASCEND Study Collaborative Group
Source: Self-asserted source
William Stevens

Effects of n- 3 Fatty Acid Supplements in Diabetes Mellitus

New England Journal of Medicine
2018 | Journal article
Contributors: ASCEND Study Collaborative Group
Source: Self-asserted source
William Stevens

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes

American Heart Journal
2017 | Journal article
Contributors: Louise Bowman,Marion Mafham,William Stevens,Richard Haynes,Theingi Aung,Fang Chen,Georgina Buck, Rory Collins, Jane Armitage
Source: Self-asserted source
William Stevens

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection

BMC nephrology
2017 | Journal article
Contributors: Reith, C; Staplin, N; Herrington, WG; Stevens, W; Emberson, J; Haynes, R; Mafham, M; Armitage, J; Cass, A; Craig, JC et al.
Source: Self-asserted source
William Stevens

Effects of anacetrapib in patients with atherosclerotic vascular disease

New England Journal of Medicine
2017 | Journal article
Contributors: HPS3/TIMI55--REVEAL Collaborative Group
Source: Self-asserted source
William Stevens

Producing CDISC compliant data and metadata for regulatory submissions

TRIALS
2017 | Conference paper
Contributors: Stevens, William; Wallendszus, Karl; Landray, Martin
Source: Self-asserted source
William Stevens

Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)—A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics

American heart journal
2017 | Journal article
Contributors: Landray, MJ; Bowman, L; Chen, F; Sammons, E; Hopewell, JC; Wallendszus, K; Stevens, W; Valdes-Marquez, E; Wiviott, S; Cannon, CP et al.
Source: Self-asserted source
William Stevens

Reveal Collaborative Group. Bowman L, et al. Randomized evaluation of the effects of anacetrapib through lipid-modification (REVEAL): a large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: trial design, recruitment, and baseline characteristics

Am Heart J
2017 | Journal article
Contributors: Landray, MJ
Source: Self-asserted source
William Stevens

Using OWL to classify adverse events

TRIALS
2017 | Conference paper
Contributors: Stevens, William; Wallendszus, Karl; Girbau, Salvador; Herrington, William; Lay, Michael; Landray, Martin
Source: Self-asserted source
William Stevens

Why use cdisc for trials not submitted to regulators? Lessons from the experience of an academic clinical trial unit

TRIALS
2017 | Conference paper
Contributors: Wallendszus, Karl; Stevens, William; Landray, Martin
Source: Self-asserted source
William Stevens

Computing with planar toppling domino arrangements

Natural Computing
2012 | Journal article
Contributors: Stevens, William M
Source: Self-asserted source
William Stevens

Time-dependent wave selection for information processing in excitable media

Physical Review E
2012 | Journal article
Contributors: Stevens, William M; Adamatzky, Andrew; Jahan, Ishrat; de Lacy Costello, Ben
Source: Self-asserted source
William Stevens

Using transition systems to describe and predict the behaviour of structured excitable media

arXiv preprint arXiv:1206.3026
2012 | Journal article
Contributors: Stevens, William M
Source: Self-asserted source
William Stevens

A self-replicating programmable constructor in a kinematic simulation environment

Robotica
2011 | Journal article
Contributors: Stevens, William M
Source: Self-asserted source
William Stevens

Computing with planar toppling domino arrangements

International Conference on Unconventional Computation
2011 | Conference paper
Contributors: Stevens, William M
Source: Self-asserted source
William Stevens

Towards a brief theory-based psychological intervention for bipolar disorder

BIPOLAR DISORDERS
2011 | Conference paper
Contributors: Miklowitz, D; Bell, S; Rendell, J; Budge, K; Foster, J; Holmes, E; Price, J; Christensen, J; Stevens, W; Wallace, J et al.
Source: Self-asserted source
William Stevens

Adapting Gosper’s Hashlife Algorithm for Kinematic Environments

CoSMoS 2010
2010 | Journal article
Contributors: Stevens, William M
Source: Self-asserted source
William Stevens

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.

Lancet
2010 | Journal article
Contributors: Lewis, S; Geddes, JR; Goodwin, G; Morriss, R; Rendell, J; Attenburrow, MJ; Carter, B; Hainsworth, J; Healey, C; Juszczak, E et al.
Source: Self-asserted source
William Stevens

The longitudinal course of bipolar disorder as revealed through weekly text messaging: a feasibility study

Bipolar disorders
2010 | Journal article
Contributors: Bopp, Jedediah M; Miklowitz, David J; Goodwin, Guy M; Stevens, Will; Rendell, Jennifer M; Geddes, John R
Source: Self-asserted source
William Stevens

A kinematic model of a self-replicating programmable constructing machine

2009 | Journal article
Contributors: Stevens, William
Source: Self-asserted source
William Stevens

Automated mood monitoring and reporting with a novel graphical method of displaying mood variation over time

BIPOLAR DISORDERS
2009 | Conference paper
Contributors: Stevens, WM; Rendell, JM; Attenburrow, MJ; Geddes, JR
Source: Self-asserted source
William Stevens

Parts closure in a kinematic self-replicating programmable constructor

Artificial Life and Robotics
2009 | Journal article
Contributors: Stevens, William M
Source: Self-asserted source
William Stevens

The longitudinal course of bipolar disorder as revealed through weekly text-messaging

BIPOLAR DISORDERS
2009 | Conference paper
Contributors: Bopp, J; Miklowitz, D; Goodwin, G; Stevens, W; Geddes, J
Source: Self-asserted source
William Stevens

Logic circuits in a system of repelling particles

International Journal of Unconventional Computing
2008 | Journal article
Contributors: Stevens, William M
Source: Self-asserted source
William Stevens
Items per page:
Page 1 of 2